Clinical characteristics and therapeutic outcome of patients with febrile neutropenia who present in shock: need for better strategies.
about
Imbalances in serum angiopoietin concentrations are early predictors of septic shock development in patients with post chemotherapy febrile neutropeniaPrognostic factors for risk stratification of adult cancer patients with chemotherapy-induced febrile neutropenia: a systematic review and meta-analysis.How we treat febrile neutropenia in patients receiving cancer chemotherapyManagement of chemotherapy-associated febrile neutropenia.Management of bacteremia in patients undergoing hematopoietic stem cell transplantation.How I manage haematology patients with septic shock.Prophylactic and therapeutic strategies in chemotherapy-induced neutropenia.Comparison of mortality between nosocomial and community-acquired febrile neutropenia patients treated initially with cefazolin plus tobramycin: retrospective chart review.Pharmacoeconomics of the myeloid growth factors: a critical and systematic review.Does procalcitonin, C-reactive protein, or interleukin-6 test have a role in the diagnosis of severe infection in patients with febrile neutropenia? A systematic review and meta-analysis.Avoidant conversations about death by clinicians cause delays in reporting of neutropenic sepsis: Grounded theory study.Aetiology of bacteraemia as a risk factor for septic shock at the onset of febrile neutropaenia in adult cancer patientsClinical validation of genetic variants associated with in vitro chemotherapy-related lymphoblastoid cell toxicity.
P2860
Q21261838-0A647F98-CE4A-4798-A248-DACD5D2E4D9AQ33412051-19E823E6-3AC4-440D-8FAD-20047896975EQ33846201-D6B9275A-B5A0-4E51-B078-D184B65326B9Q37363344-4AFA664E-9EE2-4513-A9B1-C0519945D5BFQ37503363-E144E800-4CAF-43AA-B58E-AF0DCE457DE9Q37826436-455DBCF9-D946-443B-9AA0-FF6890C3D2AAQ37831314-4F8419B8-7791-48F6-8AFE-37E8CAF0E3E8Q37942767-8F4C575E-5165-49D6-A8A1-D9FB01C14E8BQ38006021-876A6D70-EFB1-4B94-A4D2-2B9CCE9432F1Q38363320-47D7ABEF-4893-4FBF-9839-03298E6A1037Q39174846-7FB21B3A-CF43-4D94-A9CD-ABC3D7B85FD3Q42216327-038E4504-B730-40A0-B3A5-6FBDCD6B3C4BQ45746480-2E4FDF36-03F1-40BC-8694-3B5354C99808
P2860
Clinical characteristics and therapeutic outcome of patients with febrile neutropenia who present in shock: need for better strategies.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Clinical characteristics and t ...... k: need for better strategies.
@ast
Clinical characteristics and t ...... k: need for better strategies.
@en
Clinical characteristics and t ...... k: need for better strategies.
@nl
type
label
Clinical characteristics and t ...... k: need for better strategies.
@ast
Clinical characteristics and t ...... k: need for better strategies.
@en
Clinical characteristics and t ...... k: need for better strategies.
@nl
prefLabel
Clinical characteristics and t ...... k: need for better strategies.
@ast
Clinical characteristics and t ...... k: need for better strategies.
@en
Clinical characteristics and t ...... k: need for better strategies.
@nl
P2093
P356
P1433
P1476
Clinical characteristics and t ...... k: need for better strategies.
@en
P2093
P304
P356
10.1053/JINF.2001.0798
P577
2001-02-01T00:00:00Z